Stockreport

Lineage Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury

Lineage Cell Therapeutics, Inc.  (LCTX) 
PDF The DOSED Clinical Study Will Evaluate a Novel Delivery Device in Subacute and Chronic Spinal Cord Injury Patients CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell The [Read more]